Related Experiment Video

Updated: Jun 7, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Notch signaling pathway as a therapeutic target in breast cancer

Hamed Al-Hussaini1, Deepa Subramanyam, Michael Reedijk

  • 1University of Toronto, Princess Margaret Hospital, 610 University Avenue, Suite 5-222, Toronto, Ontario, M5G 2M9.

Molecular Cancer Therapeutics
|October 26, 2010
PubMed

Insights

The Notch signaling pathway regulates cellular processes and is implicated in breast cancer development and progression. Clinical trials are evaluating γ-secretase inhibitors as a potential therapeutic strategy for this disease.

Area of Science:

  • Cellular biology
  • Cancer research
  • Molecular signaling

Background:

  • The Notch signaling pathway is a highly conserved mechanism crucial for cellular processes.
  • Aberrant Notch signaling is linked to the development and progression of breast cancer.
  • This pathway presents a potential target for novel cancer therapies.

Purpose of the Study:

  • To review the role of the Notch signaling pathway in breast cancer.
  • To discuss the therapeutic potential of targeting Notch signaling.
  • To highlight ongoing clinical trials investigating Notch pathway inhibitors.

Main Methods:

  • Literature review of Notch signaling in cancer biology.
  • Analysis of preclinical and clinical data on Notch inhibitors.
  • Synthesis of information on γ-secretase inhibitors in breast cancer treatment.

Main Results:

  • Notch signaling plays a significant role in breast cancer pathogenesis.
  • γ-secretase inhibitors are being investigated as a therapeutic approach.
  • Clinical trials are assessing the efficacy and safety of these inhibitors.

Conclusions:

  • Targeting the Notch pathway holds promise for breast cancer treatment.
  • Further clinical investigation is necessary to establish the role of Notch inhibitors.
  • This strategy may offer improved outcomes for breast cancer patients.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...